BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10582132)

  • 21. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.
    Shields PG; Lerman C; Audrain J; Bowman ED; Main D; Boyd NR; Caporaso NE
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):453-8. PubMed ID: 9641486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.
    Kumar P; Gareen IF; Lathan C; Sicks JD; Perez GK; Hyland KA; Park ER
    Oncologist; 2016 Jan; 21(1):40-9. PubMed ID: 26712960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention.
    Hecht SS
    Lancet Oncol; 2002 Aug; 3(8):461-9. PubMed ID: 12147432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a genetic basis for lung cancer susceptibility?
    Amos CI; Xu W; Spitz MR
    Recent Results Cancer Res; 1999; 151():3-12. PubMed ID: 10337715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of lung cancer from environmental exposures to tobacco smoke.
    Dockery DW; Trichopoulos D
    Cancer Causes Control; 1997 May; 8(3):333-45. PubMed ID: 9498897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.
    Watanabe KH; Djordjevic MV; Stellman SD; Toccalino PL; Austin DF; Pankow JF
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):123-33. PubMed ID: 19540296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in lung cancer susceptibility: a review.
    Kiyohara C; Ohno Y
    Gend Med; 2010 Oct; 7(5):381-401. PubMed ID: 21056866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States.
    Kabat GC
    Lung Cancer; 1996 Aug; 15(1):1-20. PubMed ID: 8865119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender and lung cancer.
    Gasperino J; Rom WN
    Clin Lung Cancer; 2004 May; 5(6):353-9. PubMed ID: 15217534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial differences in cancer risk among relatives of patients with early onset lung cancer.
    Naff JL; Coté ML; Wenzlaff AS; Schwartz AG
    Chest; 2007 May; 131(5):1289-94. PubMed ID: 17400658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer: epidemiology, etiology, and prevention.
    Dela Cruz CS; Tanoue LT; Matthay RA
    Clin Chest Med; 2011 Dec; 32(4):605-44. PubMed ID: 22054876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure.
    Hammouz RY; Kostanek JK; Dudzisz A; Witas P; Orzechowska M; Bednarek AK
    J Appl Genet; 2020 Sep; 61(3):421-437. PubMed ID: 32564237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.
    Hussain SP; Hofseth LJ; Harris CC
    Lung Cancer; 2001 Dec; 34 Suppl 2():S7-15. PubMed ID: 11720736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study.
    Wu X; Hudmon KS; Detry MA; Chamberlain RM; Spitz MR
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1021-6. PubMed ID: 11045783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention.
    Hecht SS
    Ann N Y Acad Sci; 1997 Dec; 833():91-111. PubMed ID: 9616743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking the generation of DNA adducts to lung cancer.
    Ceppi M; Munnia A; Cellai F; Bruzzone M; Peluso MEM
    Toxicology; 2017 Sep; 390():160-166. PubMed ID: 28928033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.
    Strom SS; Wu S; Sigurdson AJ; Hsu TC; Fueger JJ; Lopez J; Tee PG; Spitz MR
    J Natl Cancer Inst Monogr; 1995; (18):29-33. PubMed ID: 8562219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer risk in white and black Americans.
    Stellman SD; Chen Y; Muscat JE; Djordjevic MV; Richie JP; Lazarus P; Thompson S; Altorki N; Berwick M; Citron ML; Harlap S; Kaur TB; Neugut AI; Olson S; Travaline JM; Witorsch P; Zhang ZF
    Ann Epidemiol; 2003 Apr; 13(4):294-302. PubMed ID: 12684197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.